ArticleBioinformatics advances2025
Improved prediction of antibody and their complexes with clustered generative modelling ensembles.
Article in Bioinformatics advances, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
8 citing papers in PubMed.
- Antibody-drug conjugate engineering: from design to efficacy and safety.Signal transduction and targeted therapy · 2026Review
- Combining AI Structure Prediction and Integrative Modeling for Nanobody-Antigen Complexes.Journal of chemical information and modeling · 2026Article
- AbTune: layer-wise selective fine-tuning of protein language models for antibodies.Briefings in bioinformatics · 2026Article
- DeepRank-Ab: a scoring function for antibody-antigen complexes based on geometric deep learning.Communications biology · 2026Article
- SwiftTCR: efficient computational docking protocol of TCRpMHC-I complexes using restricted rotation matrices.Briefings in bioinformatics · 2026Article
- Modeling Protein-Protein and Protein-Ligand Interactions by the ClusPro Team in CASP16.Proteins · 2026Article
- Structure-based Predictions of Conformational B Cell Epitopes by Protein Language Model and Deep Learning.bioRxiv : the preprint server for biology · 2025Article
- Predicting the conformational flexibility of antibody and T cell receptor complementarity-determining regions.Nature machine intelligence · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Motivation: Gaining structural insights into antibody-antigen complexes is crucial for understanding antigen recognition mechanisms and advancing therapeutic antibody design. However, accurate prediction of the structure of highly variable complementarity-determining region 3 on the antibody heavy chain (CDR-H3 loop) remains a significant challenge due to its increased length and conformational variability. While AlphaFold2-multimer (AF2) has made substantial progress in protein structure prediction, its application on antibodies and antibody-antigen complexes is limited by the weak evolutionary signals in the CDR region and the lack of structural diversity in its output. Results: To address these limitations, we propose a workflow that combines AlphaFlow to generate ensembles of potential loop conformations with integrative modelling of antibody-antigen complexes with HADDOCK. Improving the structural diversity of the H3 loop increases the success rate of subsequent docking tasks. Our analysis shows that while AF2 generally predicts accurate antibody structures, it struggles with the H3 loop. In cases where AF2 mispredicts the loop, we leverage AlphaFlow to generate ensembles of loop conformations via score-based flow matching, followed by clustering to produce a structurally diverse set of models. We demonstrate that these ensembles significantly improve antibody-antigen docking performance compared to the standard AF2 ensembles. Availability and implementation: The input datasets and codes involved in this research are available at https://github.com/haddocking/alphaflow-antibodies. All the resulting modelling data are available from Zenodo (https://zenodo.org/records/14906314).
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.